ストックスクリーナーアプリを入手
1.95
3.17%
0.06
アフターアワーズ：
1.91
-0.04
-2.05%
前日終値:
$1.89
開ける：
$1.8839
24時間の取引高:
10,004
Relative Volume:
0.06
時価総額：
$2.02M
収益：
-
当期純損益:
$-6.85M
株価収益率:
-0.1264
EPS:
-15.4314
ネットキャッシュフロー:
$-6.23M
1週間 パフォーマンス:
-1.52%
1か月 パフォーマンス:
-4.88%
6か月 パフォーマンス:
-69.72%
1年 パフォーマンス:
-86.82%
1日の値動き範囲:
$1.809
$1.95
1週間の範囲:
$1.649
$1.9761
52週間の値動き範囲:
$1.649
$40.80
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
名前
Bluejay Diagnostics Inc
セクター
電話
(978) 631-0152
住所
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Compare BJDX vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
1.95 | 2.02M | 0 | -6.85M | -6.23M | -15.43 |
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Bluejay Diagnostics Inc (BJDX) 最新ニュース
BJDX Technical Analysis & Stock Price Forecast - Intellectia AI
Volume Recap: Why is Bluejay Diagnostics Inc stock going down2026 Pullback Review & Weekly Top Performers Watchlists - baoquankhu1.vn
Analyst Upgrade: How is Bluejay Diagnostics Inc managing supply chain issuesNew Guidance & Real-Time Buy Zone Alerts - baoquankhu1.vn
BJDX PE Ratio & Valuation, Is BJDX Overvalued - Intellectia AI
BJDX SEC FilingsBluejay Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Bluejay Diagnostics, Inc. Enters Securities Purchase Agreement for $25,000 Private Placement of Common Stock - Minichart
Bluejay Diagnostics Announces Insider-Funded Private Stock Placement - TipRanks
Bluejay Diagnostics completes $125,000 private placement with board members - Investing.com
Bluejay Diagnostics Raises $125,000 in Insider Private Placement at $2.00 Per Share - tradingview.com
Bluejay Diagnostics (NASDAQ: BJDX) insiders purchase $125K in private stock deal - stocktitan.net
Fed Meeting: Is Bluejay Diagnostics Inc gaining market shareEntry Point & Weekly Return Optimization Alerts - baoquankhu1.vn
Bluejay Diagnostics Evaluates Potential Acquisition Opportunity While Prioritizing Core Critical Care Platform Initiatives - minichart.com.sg
Bluejay Diagnostics, Inc. announced that it has received $0.125 million in funding - marketscreener.com
Bluejay Diagnostics sends response letter to NorthStrive Fund II LP By Investing.com - Investing.com India
Bluejay Diagnostics sends response letter to NorthStrive Fund II LP - Investing.com
Bluejay Weighs Proposed Therapeutic Acquisition, Reaffirms Symphony Focus - TipRanks
Bluejay responds to investor on possible therapeutic acquisition while prioritizing Symphony platform execution - TradingView
Bluejay Diagnostics (BJDX) reviews NorthStrive proposal for cough therapy acquisition - Stock Titan
Buyout Rumor: What is Bluejay Diagnostics Incs book value per shareTrade Exit Summary & Real-Time Volume Analysis - baoquankhu1.vn
Bluejay Diagnostics, Inc. announced that it expects to receive $0.125 million in funding - marketscreener.com
Bluejay Advances Symphony IL-6 Sepsis Diagnostic Program - TipRanks
Bluejay Diagnostics: SYMON-I IL-6 Findings Accepted for SAEM 2026 Presentation - TradingView
Bluejay Diagnostics (NASDAQ: BJDX) highlights SYMON-I IL-6 sepsis data at 2026 SAEM - Stock Titan
Bluejay Diagnostics to Present Findings on IL-6 as a Biomarker for Sepsis at 2026 SAEM Annual Meeting - Quiver Quantitative
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting - The Manila Times
Study explores link between ER inflammation marker and organ damage in sepsis - Stock Titan
Northstrive Fund II has sent a letter to the Board of Directors of Bluejay Diagnostics Inc, recommending that they carefully evaluate a potential acquisition opportunity. - Bitget
NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics - The Manila Times
Braeden Lichti Pushes for Changes at Bluejay Diagnostics with 3.65% Stake - TradingView
Activist investor presses deal at Bluejay Diagnostics (NASDAQ: BJDX) - Stock Titan
Activist investor files 13D in Bluejay Diagnostics (BJDX), pushes biotech acquisition review - Stock Titan
Investor presses Bluejay Diagnostics (NASDAQ: BJDX) on biotech acquisition idea - Stock Titan
Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook - marketscreener.com
Aug Opening: Is Bluejay Diagnostics Inc a good ESG investmentMarket Sentiment Report & Technical Pattern Based Buy Signals - baoquankhu1.vn
Bluejay 10-K: Net loss $6.85M, operating loss $6.95M; cash through Q3 2026 - TradingView
Medical diagnostics company Bluejay Diagnostics Inc (stock code: BJDX) is facing financial pressure. According to the company's latest disclosed financial plan, in order to maintain normal operations and advance R&D projects, it must secure at least $20 milli - Bitget
Bluejay Diagnostics says SYMON II study ‘progressing as planned’ - TipRanks
Bluejay’s 20-minute sepsis test drives 2026 plan and $20M cash goal - Stock Titan
Bluejay Diagnostics, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
BJDX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BJDX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
BJDX Should I Buy - Intellectia AI
ARMISTICE CAPITAL, LLC Acquires Shares in Bluejay Diagnostics Inc - GuruFocus
BJDXBluejay Diagnostics Inc Latest Stock News & Market Updates - Stock Titan
Why is Bluejay Diagnostics Inc. stock going downWeekly Trade Summary & Reliable Momentum Entry Alerts - mfd.ru
Bluejay Diagnostics Completes Warrant Exercises, Clarifies Capital Structure - TipRanks
Bluejay Diagnostics clears prefunded warrants after full exercise - MSN
Bluejay Diagnostics says all prefunded warrants exercised; ~972,000 shares outstanding, 1.5M cash-exercise warrants - TradingView
Bluejay Diagnostics’ Clinical Study Marks Key Transition from Enrollment to Data Analysis - StocksToTrade
Prefunded warrants fully exercised at Bluejay Diagnostics (NASDAQ: BJDX) - Stock Titan
Bluejay Diagnostics completes prefunded warrant exercises By Investing.com - Investing.com Canada
Bluejay Diagnostics Inc (BJDX) 財務データ
収益
当期純利益
現金流量
EPS
0.15%
大文字化:
|
ボリューム (24 時間):